Organizations we have worked with

Partnerships that move complex work forward

Biotica works between organizations when a healthcare or life-science project needs more than an introduction. We help teams operate telehealth and e-prescribing workflows, navigate markets, frame research questions, shape study methodology, translate technical requirements, coordinate GMP-documented API supply, manage OEM handoffs, and keep documentation moving with the work.

BioticaCoordination layer

Healthcare operations, technology, research, product, laboratory, manufacturing, and market teams connected around one defined objective.

Biotica between the teams

The work that turns separate capabilities into one program

The exact scope changes by engagement. These are the recurring coordination layers Biotica can bring when work crosses company, laboratory, supplier, manufacturer, and market boundaries.

Market navigation

Market context, opportunity questions, regional constraints, and commercialization paths are clarified before teams commit resources.

Research planning

Scientific questions are translated into literature reviews, formulation briefs, testable objectives, and practical next studies.

Study methodology

Sponsors and research teams align on what a method can measure, the controls it needs, and the limits that must remain visible.

Cross-party communication

Technical requirements and open decisions are carried between sponsors, laboratories, suppliers, manufacturers, and commercial teams.

Supply, OEM handoffs, and documentation

Product and supply intent is converted into usable specifications, process guardrails, quality questions, evidence records, and decision-ready documentation.

Partner profiles

Organizations connected to documented work

These profiles describe project-specific working relationships and the capabilities each organization brought into the work. They do not imply exclusivity or a universal endorsement of every service offered by an organization.

Rendered SulfoGenz bottles and carton from the FolliGenz formulation program
Research-driven product and technology collaborator

FolliGenz Therapeutics Corporation

United States

FolliGenz is a research-driven biotechnology company developing cosmetic and dermatological formulations and early research technologies. Biotica has supported programs that connect scientific rationale, market questions, formulation development, third-party testing, manufacturing communication, and public-facing technical documentation.

The relationship has included literature and market research, formulation strategy, research-question development, CRO coordination, interpretation of laboratory outputs, OEM and supplier communication, and disciplined claim boundaries. Biotica helps keep the original question, the evidence produced, and the next validation step connected as a project moves between organizations.

Formulation researchMarket and literature analysisCRO coordinationTechnology methodologyTechnical documentation
Visit FolliGenz
Pilot scalp-serum samples prepared during FolliGenz and Hemu Haohai development work
API, formulation, OEM, and international execution partner

Nanjing Hemu Haohai Biotechnology Co., Ltd.

Nanjing, Jiangsu, China

Hemu Haohai connects life-science ingredient and API expertise with international product development. Its role can extend from sourcing and technical review into formulation cooperation, factory feasibility, pilot samples, OEM coordination, quality documentation, packaging, and export execution.

Biotica has worked with Hemu Haohai in cross-border programs where a scientific product concept had to become an executable factory brief. The work has included translating research rationale into manufacturing requirements, coordinating decisions between FolliGenz, Hemu Haohai, and OEM teams, tracking prototype and documentation questions, and keeping market and quality expectations visible during the handoff.

API and ingredient supportFormulation cooperationOEM coordinationPilot samplingQuality and export documentation
Visit Hemu Haohai
Confocal Raman depth maps from the CTI-reported minoxidil-sulfate study
CTIBiotechnology (Suzhou)
Preclinical research and testing partner within the CTI network

CTI Biotechnology (Suzhou) Co., Ltd.

Kunshan, Suzhou, Jiangsu, China

CTI Biotechnology (Suzhou) is a preclinical CRO within the wider Centre Testing International network. Its published service scope includes early screening, pharmacodynamics, pharmacokinetics, safety evaluation, toxicokinetics, and bioanalysis for small molecules and biopharmaceutical programs.

Biotica has worked with CTI organizations to translate sponsor questions into measurable studies, discuss methodology and evidence limits, coordinate technical communication, and interpret results for the next formulation decision. The documented FolliGenz Raman program was issued by Centre Testing International Group Co., Ltd., while CTI Biotechnology (Suzhou) is the network's specialist preclinical CRO. Each project record identifies the exact CTI entity and testing scope involved.

Preclinical researchStudy-method discussionBioanalysis and safety servicesSponsor-laboratory coordinationEvidence interpretation

Related documented work

Entity note: The Raman report names Centre Testing International Group Co., Ltd. as the testing organization. The Suzhou CRO profile reflects its role within the wider CTI network and does not reassign that specific study to the Suzhou facility.

Visit CTI Group
Abstract pathways representing active pharmaceutical ingredient coordination from India to international partners
EVIDENTLabs · India
India-based API sourcing and cross-border supply partner

Evident Labs

India

Evident Labs has worked with Biotica on India-based sourcing and cross-border coordination for GMP-documented active pharmaceutical ingredients. The work connected supplier-side quotations and quality documentation with partner requirements in Saudi Arabia, Brazil, Argentina, Australia, and additional markets.

Biotica helped translate partner demand into product, grade, quantity, documentation, and destination-market questions. We coordinated communication between Evident Labs, manufacturers, and receiving partners, kept GMP and product-document requests moving, and surfaced import, shipping, and market-specific diligence items before commercial handoff. Evident Labs contributed India-side supply access, quotations, documentation packages, and export coordination.

GMP-documented API supplyIndia-side supplier accessQuality-document handoffsCross-border partner communicationCommercial and export coordination

Related Biotica capability

Scope note: Specific GMP certificates, manufacturers, products, batches, shipping terms, and destination-market import requirements are confirmed for each transaction. This profile does not imply that one certificate or approval covers every API or market.

Blue and orange pathways representing API, custom-synthesis, and technical coordination with Hubei Vanzpharm
API, custom synthesis, and scale-up partner

Hubei Vanzpharm Co., Ltd.

Wuhan, Hubei, China

Hubei Vanzpharm supports API supply, custom synthesis, medicinal and organic chemistry research, process development, technology transfer, scale-up, and commercial-production pathways. Its official service profile describes synthesis and analytical laboratories, pilot-scale capability, and manufacturing equipment designed to move work from research into production.

Biotica has worked with Vanzpharm in API supply intelligence and technical supplier coordination. We help organize product requirements, source and manufacturing questions, documentation requests, commercial comparisons, and communication between Vanzpharm and downstream partners. Vanzpharm contributes China-side API access, custom-synthesis and process-development context, and practical scale-up discussion for project-specific supply decisions.

API and research-product supplyCustom synthesisProcess development and optimizationLaboratory and commercial scale-upTechnical supplier coordination

Related Biotica capability

Qualification note: Product identity, manufacturing site, current specifications, analytical methods, quality records, regulatory status, and destination-market requirements are confirmed for each engagement.

Visit Vanzpharm
Connected digital-care pathways representing the NoTimeRx telehealth MSO platform
Healthcare MSO and telehealth coordination platform

NoTimeRx

United States

NoTimeRx is a non-clinical healthcare Management Services Organization and telehealth coordination platform that connects patients, independent licensed providers, and compounding pharmacies. The MSO supports administrative, technical, and operational workflows while clinical decisions remain with providers and compounding and dispensing remain with licensed pharmacies.

Biotica project records state that members of Biotica Consulting LLC helped finance NoTimeRx through grant support and that Biotica Consulting engineers operate and maintain the platform. The work includes platform engineering, third-party integrations, workflow operations, testing, documentation, and coordination across patient, provider, e-prescribing, and pharmacy handoffs.

Healthcare MSO operationsTelehealth workflow coordinationPlatform engineering and maintenanceE-prescribing integrationProvider and pharmacy handoffs

Related documented work

Role boundary: NoTimeRx and Biotica do not provide medical care, make prescribing decisions, or dispense medication. Independent licensed providers and licensed pharmacies retain those responsibilities.

Visit NoTimeRx
Secure digital prescription pathways representing the DoseSpot e-prescribing integration
E-prescribing technology partner used by NoTimeRx

DoseSpot

United States

DoseSpot, now an Interra Health solution, provides certified e-prescribing technology for healthcare and telehealth workflows. Its official materials describe prescription transmission, pharmacy selection, identity-proofing and authentication workflows, clinical decision support, electronic prior authorization, and controlled-substance capabilities where configured and authorized.

DoseSpot provides the third-party e-prescribing platform used in the NoTimeRx workflow. Biotica engineers operate the surrounding NoTimeRx platform and coordinate the integration so authorized prescribers can securely transmit prescriptions to selected participating pharmacies, including participating 503A compounding pharmacies where applicable. NoTimeRx reports that supported routing in its configuration uses the Surescripts network.

E-prescribing integrationTelehealth workflow supportPharmacy selection and routingIdentity and authentication workflowsEPCS and prescribing controls

Related documented work

Network note: DoseSpot is third-party technology. Surescripts is underlying network infrastructure used in the configured workflow, not a direct Biotica integration. Routing, certification, pharmacy participation, acceptance, and provider responsibilities remain subject to current third-party requirements.

Visit DoseSpot
A project-specific network

The right relationship starts with a clearly defined scope

Every collaboration is structured around the decision, geography, evidence, contracting entities, facilities, and documentation required for that project. Capabilities, availability, accreditations, and regulatory suitability are confirmed for the engagement at hand.

Abstract streams representing coordinated technical information moving between organizations
Build the working group

Need the market, research, and execution teams aligned?

Bring us the product question, study need, technology plan, or cross-border handoff. We can help define the work and coordinate the organizations needed to move it forward.

Start a conversation